ADTXAditxt, Inc.

Nasdaq aditxt.com


$ 0.90 $ -0.05 (-5.26 %)    

Friday, 23-Aug-2024 15:01:19 EDT
QQQ $ 479.76 $ 0.99 (0.21 %)
DIA $ 411.97 $ 4.35 (1.07 %)
SPY $ 562.00 $ 5.78 (1.04 %)
TLT $ 98.37 $ 0.62 (0.63 %)
GLD $ 231.99 $ 1.03 (0.45 %)
$ 0.8976
$ 0.91
$ 0.88 x 200
$ 0.90 x 400
$ 0.90 - $ 0.91
$ 0.89 - $ 68.08
178,460
na
3.42M
$ 3.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 04-17-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Aditxt, Inc. ("Aditxt" or "the Company") (NASDAQ:ADTX), an innovation platform dedicated to discovering, develo...

Core News & Articles

As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Bioscie...

Core News & Articles

Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious diseas...

 whats-going-on-with-aditxt-shares-wednesday

Aditxt and Evofem amended and restated their merger agreement.

Core News & Articles

This amended and restated Merger Agreement, among others, addresses pre-closing issues critical for Evofem's future success...

 evofem-biosciences-announces-issuance-of-us-patent-no-11992472-covering-composition-and-methods-for-contraception-with-phexxi-vaginal-gel

- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio --- Newly issued patent...

 aditxt-announces-pricing-of-42m-private-placement-priced-at-the-market-under-nasdaq-rules

Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a company dedicated to discovering, developing, and dep...

 why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

 why-aditxt-stock-is-volatile-today

Aditxt's wholly owned subsidiary, Adivir, Inc. will acquire all issued and outstanding Class A common shares of Appili in t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION